Mathers Edward T
SEC-identified person · CIK 1328625 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Reneo Pharmaceuticals, Inc. RPHM | Director | filed 2021–2026 |
| MBX Biosciences, Inc. MBX | Director | filed 2024–2026 |
| Trevi Therapeutics, Inc. TRVI | Director | filed 2019–2026 |
| Rhythm Pharmaceuticals, INC. SRYTM | Director | filed 2017–2026 |
| Korro Bio, Inc. KRRO | Officer | filed 2023–2026 |
| Spyglass Pharma, Inc. SPG | Officer | filed 2026–2026 |
| Neuehealth, Inc. NEUE | Director | filed 2021–2025 |
| Senti Biosciences, Inc.\ SNTI | Director | filed 2022–2025 |
| Inozyme Pharma, Inc. INZY | Director | filed 2020–2024 |
| Savara Inc [ANX] | Officer | filed 2021–2023 |
| Synlogic, INC. SYBX | Director | filed 2015–2023 |
| Obseva SA OBSV | Director | filed 2023–2023 |
| Akouos, Inc. AKUS | Director | filed 2020–2022 |
| Mirum Pharmaceuticals, Inc. MIRM | Director | filed 2019–2022 |
| Monte Rosa Therapeutics, Inc. GLUE | Officer | filed 2021–2021 |
| Ra Pharmaceuticals, Inc. RARX | Director | filed 2016–2020 |
| Liquidia Technologies Inc LQDA | Director | filed 2018–2018 |
| Medimmune INC /DE MEDI | SVP, Corporate Development | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.